CIK 0001100682 · Large accelerated filer
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Sign in to watch- Ticker
- CRL
- Exchange
- NYSE
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 27
- Entity type
- operating
- EIN
- 061397316
- Phone
- 781-222-6000
- Business address
- 251 BALLARDVALE ST, WILMINGTON, MA, 01887
- Former names
- CHARLES RIVER LABORATORIES INTERNATIONAL INC, CHARLES RIVER LABORATORIES HOLDINGS INC
- Open-market buys, last 90 days
- $2,974
- in 1 filing
- Open-market sales, last 90 days
- $20,291,281
- in 6 filings, $20.1M under 10b5-1 plans
Net −$20,288,307. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-06 | LaPlume Joseph W EVP, Corp Strategy & Develop | Sale | −1,042 | $402.43 | $419K | 8,762 |
| 2021-08-06 | LaPlume Joseph W EVP, Corp Strategy & Develop | Sale | −300 | $409.40 | $123K | 8,462 |
| 2021-08-06 | Barbo William D Corporate Executive VP & CCO | Option exercise | +3,204 | $109.34 | $350K | 12,490 |
| 2021-08-06 | Barbo William D Corporate Executive VP & CCO | Option exercise | +2,755 | $144.67 | $399K | 15,245 |
| 2021-08-06 | Barbo William D Corporate Executive VP & CCO | Option exercise | +1,513 | $179.66 | $272K | 16,758 |
| 2021-08-06 | Barbo William D Corporate Executive VP & CCO | Sale | −2,944 | $400.83 | $1.2M | 13,814 |
| 2021-08-06 | Barbo William D Corporate Executive VP & CCO | Sale | −3,253 | $401.62 | $1.3M | 10,561 |
| 2021-08-06 | Barbo William D Corporate Executive VP & CCO | Sale | −2,380 | $402.64 | $958K | 8,181 |
| 2021-08-06 | Barbo William D Corporate Executive VP & CCO | Sale | −726 | $403.60 | $293K | 7,455 |
| 2021-08-06 | Barbo William D Corporate Executive VP & CCO | Sale | −692 | $404.82 | $280K | 6,763 |
| 2021-08-06 | Barbo William D Corporate Executive VP & CCO | Sale | −1,685 | $405.58 | $683K | 5,078 |
| 2021-08-06 | Barbo William D Corporate Executive VP & CCO | Sale | −7 | $406.52 | $3K | 5,071 |
| 2021-08-06 | Barbo William D Corporate Executive VP & CCO | Sale | −500 | $407.45 | $204K | 4,571 |
| 2021-08-06 | Barbo William D Corporate Executive VP & CCO | Sale | −200 | $409.08 | $82K | 4,371 |
| 2021-08-06 | Barbo William D Corporate Executive VP & CCO | Option exercise · Stock Options (Right to Buy) | −3,204 | 3,205 | ||
| 2021-08-06 | Barbo William D Corporate Executive VP & CCO | Option exercise · Stock Options (Right to Buy) | −2,755 | 5,511 | ||
| 2021-08-06 | Barbo William D Corporate Executive VP & CCO | Option exercise · Stock Options (Right to Buy) | −1,513 | 4,541 | ||
| 2021-08-06 | Kochevar Deborah Turner Director | Option exercise | +2,539 | $164.24 | $417K | 9,622 |
| 2021-08-06 | Kochevar Deborah Turner Director | Sale | −901 | $405.73 | $366K | 8,721 |
| 2021-08-06 | Kochevar Deborah Turner Director | Sale | −2,620 | $406.67 | $1.1M | 6,101 |
Page 37 of 41 · 819 trades